Clinical Trials
Biomarkers in LBD, a clinical study by the DLB Consortium (DLBC)
What is this study about? The purpose of this study is to collect clinical information, brain imaging scans, and biological samples from people that have dementia with Lewy bodies. This […]
Read More
New Lewy Body Disorders Study at Columbia University
What is this study about? The aim of this study is to develop better biomarkers for diagnosis and treatment of Lewy body disorders. In particular, there is a need to […]
Read More
Harvard LBD Biomarker Study (Boston, MA)
People with LBD (including dementia with Lewy bodies and Parkinson’s disease dementia) experience life-altering changes in their cognitive abilities. This affects the quality of life for both the person with […]
Read More
Lewy Body Dementia Biomarkers Study at University of Michigan
People with LBD present with different combinations of symptoms and severity, which can make diagnosis a challenge. Understanding whether one or more disease processes are underway may help diagnose and […]
Read More